The Two-Track Investigation of Fibronectin Binding Protein A of Staphylococcus aureus from Bovine Mastitis as a Potential Candidate for Immunodiagnosis: A Pilot Study.
Anna DobrutAgata MlodzinskaKamil DrożdżDagmara WojcikKatarzyna MichalakDorota Pietras-OżgaJolanta KarakulskaKatarzyna BiegunMonika Brzychczy-WłochPublished in: International journal of molecular sciences (2023)
Bovine mastitis is the most common disease affecting dairy cattle worldwide and it generates substantial losses for cattle breeders. One of the most common pathogens identified in infected milk samples is Staphylococcus aureus . Currently, there is no fast test for recognizing bacteria species on the market. The aim of this study was to bioinformatically and laboratory detect and characterize the fibronectin binding protein A (FnBPA) of S. aureus (SA) in milk samples obtained from cows diagnosed with mastitis. More than 90,000,000 amino acid sequences were subjected to bioinformatic detection in the search for a potential biomarker for bovine SA. The analysis of FnBPA included the detection of signal peptides and nonclassical proteins, antigenicity, and the prediction of epitopes. To confirm the presence of the fnb A gene in four SA isolates, amplification with specific primers was performed. FnBPA was detected by immunoblotting. The immunoreactivity and selectivity were performed with monoclonal anti-FnBPA antibodies and SA-negative serum. The bioinformatic analysis showed that FnBPA is a surface, conservative, immunoreactive, and species-specific protein with antigenic potential. Its presence was confirmed in all of the SA isolates we studied. Immunoblotting proved its immunoreactivity and specificity. Thus, it can be considered a potential biomarker in mastitis immunodiagnostics.
Keyphrases
- binding protein
- staphylococcus aureus
- amino acid
- genetic diversity
- label free
- loop mediated isothermal amplification
- real time pcr
- type iii
- human health
- gram negative
- escherichia coli
- genome wide
- small molecule
- copy number
- methicillin resistant staphylococcus aureus
- risk assessment
- antimicrobial resistance
- health insurance
- transcription factor
- multidrug resistant